NEMAURA MEDICAL INC (NMRD) Stock Analyst Earnings Estimates
NASDAQ:NMRD - Nasdaq - US6404422080 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 500K | 80K -84.00% | 408K 410.00% | 3.264M 700.00% | ||
| EBITDA YoY % growth | -4.49M 5.07% | -7.34M -63.47% | -6.7M 8.72% | N/A | N/A | |
| EBIT YoY % growth | -4.59M 3.97% | -7.57M -64.92% | -7.14M 5.68% | -8.23M -15.27% | -6.701M 18.58% | |
| Operating Margin | N/A | -1,514.00% | -8,925.00% | -2,017.25% | -205.31% | |
| EPS YoY % growth | N/A 1.64% | -0.59 -114.23% | -0.59 0.00% | -0.34 42.95% | -0.37 -9.09% |
All data in USD
| Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 -45.71% | -0.10 43.33% | -0.10 -13.33% | -0.10 -93.80% | -0.09 15.00% | -0.08 20.00% |
| Revenue Q2Q % growth | 102K | 306K | 510K | 663K | 816K 700.00% | 1.326M 333.33% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.05M -225.43% | -1.989M -8.69% | -1.734M 15.83% | -1.734M 15.41% | -1.734M 15.42% | -1.428M 28.21% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -0.05 70.59% | -0.11 | 0.06 | 55.44% |
| Q1 2024 Q2Q % growth | -0.09 47.06% | -0.15 | 0.06 | 41.18% |
| Q4 2023 Q2Q % growth | -0.18 -20.00% | -0.16 | -0.02 | -10.29% |
| Q3 2023 Q2Q % growth | -0.07 53.33% | -0.18 | 0.11 | 61.87% |
| Q2 2023 Q2Q % growth | -0.17 -13.33% | -0.17 | 0.00 | 1.96% |
| Q1 2023 Q2Q % growth | -0.17 -21.43% | -0.17 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.15 -66.67% | -0.14 | -0.01 | -7.60% |
| Q3 2022 Q2Q % growth | -0.15 | -0.14 | -0.01 | -5.04% |
| Q2 2022 Q2Q % growth | -0.15 | -0.11 | -0.04 | -33.69% |
| Q1 2022 Q2Q % growth | -0.14 | -0.08 | -0.06 | -71.57% |
| Q4 2021 Q2Q % growth | -0.09 -50.00% | -0.08 | -0.01 | -10.29% |
| Q2 2021 Q2Q % growth | -0.15 -50.00% | % | ||
| Q1 2021 Q2Q % growth | -0.14 -40.00% | % | ||
| Q4 2020 Q2Q % growth | -0.06 -200.00% | % | ||
| Q3 2020 Q2Q % growth | -0.02 80.00% | -0.10 | 0.08 | 80.39% |
| Q2 2020 Q2Q % growth | -0.10 | -0.10 | 0.00 | 1.96% |
| Q1 2020 Q2Q % growth | -0.10 | -0.10 | 0.00 | 1.96% |
| Q2 2019 Q2Q % growth | -0.10 | -0.10 | 0.00 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q1 2024 Q2Q % growth | 153K | -153K | -100.00% | |
| Q4 2023 Q2Q % growth | -100.00% | 204K | -204K | -100.00% |
| Q3 2023 Q2Q % growth | -100.00% | 170.003K | -170.003K | -100.00% |
| Q2 2023 Q2Q % growth | 70K | 204K | -134K | -65.69% |
| Q1 2023 Q2Q % growth | 459K | -459K | -100.00% | |
| Q4 2022 Q2Q % growth | 320K | 316.2K | 3.8K | 1.20% |
| Q3 2022 Q2Q % growth | 180K | 153K | 27K | 17.65% |
| Q2 2022 Q2Q % growth | 204K | -204K | -100.00% | |
| Q3 2020 Q2Q % growth | 408K | -408K | -100.00% | |
| Q2 2020 Q2Q % growth | 204K | -204K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 9.09% | 0% | 18.52% |
| Revenue | 0% | -33.33% | 0% | -44.83% |